A Double‐Blind, Placebo‐Controlled, Multicenter Study of Cerebrolysin for Alzheimer's Disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-5415|48|12|1566-1571

ISSN： 0002-8614

Source： JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol.48, Iss.12, 2000-12, pp. : 1566-1571

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nicergoline in Mild to Moderate Dementia: A Multicenter, Double‐Blind, Placebo‐Controlled Study

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 37, Iss. 4, 1989-04 ,pp. : 295-302

John Wiley & Sons Inc

Access to resources Recommend Favorite

The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: A randomized, double‐blind, placebo‐controlled, multicenter study

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 7, 2015-06 ,pp. : 1009-1009

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Randomized, Double‐Blind, Placebo‐Controlled Multicenter Study of Adalimumab in Pediatric Patients With Enthesitis‐Related Arthritis

By  

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 11, 2015-11 ,pp. : 1503-1512

John Wiley & Sons Inc

Access to resources Recommend Favorite

Greater occipital nerve blockade for the treatment of chronic migraine: a randomized, multicenter, double‐blind, and placebo‐controlled study

By  

ACTA NEUROLOGICA SCANDINAVICA (ELECTRONIC), Vol. 132, Iss. 4, 2015-10 ,pp. : 270-277

John Wiley & Sons Inc

Access to resources Recommend Favorite

Apremilast in Patients With Active Rheumatoid Arthritis: A Phase II, Multicenter, Randomized, Double‐Blind, Placebo‐Controlled, Parallel‐Group Study

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 7, 2015-07 ,pp. : 1703-1710

John Wiley & Sons Inc

Access to resources Recommend Favorite